LANTHANUM-MOLYBDENUM COMPLEX OXIDE, ANTIBACTERIAL SINTERED BODY, AND ANTIVIRAL SINTERED BODY

To provide a lanthanum-molybdenum complex oxide etc. which has both an excellent antibacterial property and antiviral property.SOLUTION: A lanthanum-molybdenum complex oxide comprises La2Mo2O9 as a main crystalline phase and a lanthanum-molybdenum complex oxide other than the La2Mo2O9 as a secondary...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KUROKAWA MITSUO, KOZUKA HISASHI, MATSUMOTO TAKUMI, NAKAJIMA AKIRA
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY CHEMISTRY COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F INORGANIC CHEMISTRY METALLURGY PERFORMING OPERATIONS PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL THEIR RELEVANT APPARATUS TRANSPORTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide a lanthanum-molybdenum complex oxide etc. which has both an excellent antibacterial property and antiviral property.SOLUTION: A lanthanum-molybdenum complex oxide comprises La2Mo2O9 as a main crystalline phase and a lanthanum-molybdenum complex oxide other than the La2Mo2O9 as a secondary crystalline phase. The main crystalline phase and the secondary crystalline phase in the lanthanum-molybdenum complex oxide can be specified by analyzing an X-ray diffraction spectrum obtained by powder X-ray diffractometry.SELECTED DRAWING: Figure 1 【課題】優れた抗菌性及び抗ウイルス性を併せ持ったランタン・モリブデン複合酸化物等の提供。【解決手段】ランタン・モリブデン複合酸化物は、Ｌａ２Ｍｏ２Ｏ９を主結晶相とし、前記Ｌａ２Ｍｏ２Ｏ９以外のランタン・モリブデン複合酸化物を副結晶相とするものであって、ランタン・モリブデン複合酸化物における主結晶相及び副結晶相は、粉末Ｘ線回折法により得られるＸ線回折スペクトルを解析することにより、特定することができる。【選択図】図１